Ardelyx reported $229.21M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Abbott USD 12.93B 194M Jun/2025
Amgen USD 53.76B 253M Jun/2025
Ardelyx USD 229.21M 78.36M Jun/2025
Corcept Therapeutics USD 0 0 Mar/2025
Life Technologies USD 602K 285K Jun/2025
Sanofi 14.72B 2.93B Jun/2025
TG Therapeutics USD 245.04M 608K Jun/2025
United Therapeutics USD 0 0 Mar/2025